Aditi Kadakia, MS

Hospitalization Risk in Pediatric Bipolar Patients Treated with Lurasidone vs. Other Oral Atypical Antipsychotics: A Real-World Retrospective Claims Database Study

Background: Real-world evidence on atypical antipsychotic (AAP) use in pediatric bipolar disorder is limited. Objective: To compare the risk of all-cause and psychiatric hospitalization ...

Li Wang , MS, MBA, PhD, MA;

Daisy Ng-Mak , PhD;

Sulena Shrestha , MPH;

Aditi Kadakia , MS;

Antony Loebel , MD;

11/22/2019

The Incidence and Economic Burden of Extrapyramidal Symptoms in Patients with Schizophrenia Treated with Atypical Antipsychotics

Background: Extrapyramidal symptoms (EPS), including movement disorders, tremors, and muscle contractions are common side effects of atypical antipsychotic (AAP) drugs in patients with sc...

Aditi Kadakia , MS;

Huan Huang , PhD;

Carole Dembek , MS;

Rhys Williams , PhD;

Justine Kent , MD;

Brenna Brady , PhD;

10/08/2020

Psychiatric inpatient healthcare resource utilization and treatment patterns among patients with predominant negative symptoms in schizophrenia

Abstract: Currently-approved treatments for schizophrenia have demonstrated effectiveness for treating positive symptoms. There is a need to develop effective treatments for negative symp...

Aditi Kadakia , MS;

Rashmi Patel , DO;

01/19/2023